Enovis (ENOV) Share-based Compensation Growth (1y) (2011 - 2026)
Powered by 
Analysis
Enovis (ENOV) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 12.53% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | 10.53% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | -13.91% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 7.56% |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn | 3.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 3.46% |
| Apr 3, 2026 | 18.13% |
| Dec 31, 2025 | 131.46% |
| Apr 4, 2025 | -93.13% |
| Dec 31, 2024 | -849.99% |
| Mar 29, 2024 | 12,773.15% |
| Dec 31, 2023 | -25.54% |
| Sep 29, 2023 | 9.63% |
| Jun 30, 2023 | 62.47% |
| Mar 31, 2023 | -91.50% |
| Dec 31, 2022 | 1,115,700.00% |
| Sep 30, 2022 | -97.02% |
| Jul 1, 2022 | 5.09% |
| Apr 1, 2022 | 26.26% |
| Dec 31, 2021 | -100.01% |
| Oct 1, 2021 | 3,758.26% |
| Jul 2, 2021 | 10.44% |
| Apr 2, 2021 | 27.48% |
| Dec 31, 2020 | 46.70% |
| Oct 2, 2020 | 19.21% |